The global amniotic membrane market was valued at $812 million in 2016, and is expected to reach $1,563 million by 2023, registering a CAGR of 9.7% during the forecast period. Amniotic membrane is the inmost layer of the placenta, which includes a thick basement membrane or a tissue and an avascular stromal matrix. It can be further used as a graft, as a dressing to facilitate ocular surface reconstruction, and promote healing for various ailments. The major factors that drive the growth of amniotic membrane market are growth of the geriatric population coupled with the increase in amniotic membrane transplantation globally. However, dearth of skilled professionals is expected to be a key restraint for this growth. Moreover, rise in awareness regarding the potential benefits of amniotic membrane may create lucrative opportunities for the patients, which would further boost the market growth.

CHAPTER 1: INTRODUCTION

1.1. Report description

1.2. Key benefits for stakeholders

1.3. Key market segments

1.4. Research methodology

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market Definition And Scope

3.2. Key findings

3.2.1. Top investment pockets

3.2.2. Top winning strategies

3.2.3. Top winning strategies, by year, 2014-2017*

3.2.4. Top winning strategies, by development, 2014-2017* (%)

3.2.5. Top winning strategies, by company, 2014-2017*

3.3. Porter’s Five Forces Analysis

3.4. Top player positioning

3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Growth in geriatric population

3.5.1.2. Numerous technological advancements and rise in amniotic

membrane transplantations

3.5.1.3. Increased awareness to reduce healthcare costs

3.5.2. Restraint

3.5.2.1. Dearth of skilled professionals

3.5.3. Opportunity

3.5.3.1. Rise in awareness about the advantages of amniotic membrane

transplant

CHAPTER 4: AMNIOTIC MEMBRANE MARKET, BY PRODUCT

4.1. Overview

4.2. Market size and forecast

4.3. Cryopreserved amniotic membrane

4.3.1. Key market trends, growth factors, and opportunities

4.3.2. Market size and forecast, by region

4.4. Lyophilization amniotic membrane

4.4.1. Key market trends, growth factors, and opportunities

4.4.2. Market size and forecast, by region

CHAPTER 5: AMNIOTIC MEMBRANE MARKET, BY APPLICATION                                          

5.1. Overview

5.1.1. Market size and forecast

5.2. Surgical wounds

5.2.1. Market size and forecast, by region

5.3. Ophthalmology

5.3.1. Market size and forecast, by region

5.4. Others

5.4.1. Market size and forecast, by region

CHAPTER 6: AMNIOTIC MEMBRANE MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Hospitals

6.2.1. Market size and forecast, by region

6.3. Ambulatory surgical centers

6.3.1. Market size and forecast, by region

6.4. Specialized clinics

6.4.1. Market size and forecast, by region

6.5. Research center & laboratories

6.5.1. Market size and forecast, by region

CHAPTER 7: AMNIOTIC MEMBRANE MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. North America market size and forecast, by country

7.2.2. North America market size and forecast, by product

7.2.3. North America market size and forecast, by application

7.2.4. North America market size and forecast, by end User

7.2.4.1. U.S. market size and forecast, by product

7.2.4.2. U.S. market size and forecast, by application

7.2.4.3. U.S. market size and forecast, by end user

7.2.4.4. Canada market size and forecast, by product

7.2.4.5. Canada market size and forecast, by application

7.2.4.6. Canada market size and forecast, by end user

7.2.4.7. Mexico market size and forecast, by product

7.2.4.8. Mexico market size and forecast, by application

7.2.4.9. Mexico market size and forecast, by end user

7.3. Europe

7.3.1. Europe market size and forecast, by product

7.3.2. Europe market size and forecast, by application

7.3.3. Europe market size and forecast, by end user

7.4. Asia-Pacific

7.4.1. Asia-Pacific market size and forecast, by product

7.4.2. Asia-Pacific market size and forecast, by application

7.4.3. Asia-Pacific market size and forecast, by end user

7.5. LAMEA

7.5.1. LAMEA market size and forecast, by product

7.5.2. LAMEA market size and forecast, by application

7.5.3. LAMEA market size and forecast, by end user

CHAPTER 8: COMPANY PROFILES

8.1. Alliqua BioMedical Inc.

8.1.1. Company overview

8.1.2. Company snapshot

8.1.3. Business performance

8.1.4. Key strategic moves and developments

8.2. Amnio Technology, LLC

8.2.1. Company overview

8.2.2. Company snapshot

8.2.3. Key strategic moves and developments

8.3. Applied Biologics LLC

8.3.1. Company overview

8.3.2. Company snapshot

8.4. FzioMed Inc.

8.4.1. Company overview

8.4.2. Company snapshot

8.5. Human Regenerative Technologies, LLC

8.5.1. Company overview

8.5.2. Company snapshot

8.6. Integra Lifesciences Holdings Corporation (Derma Sciences Inc.)

8.6.1. Company overview

8.6.2. Company snapshot

8.6.3. Operating business segments

8.6.4. Business performance

8.6.5. Key strategic moves and developments

8.7. Katena Products, Inc. (IOP Ophthalmics)

8.7.1. Company overview

8.7.2. Company snapshot

8.8. MiMedx Group Inc.

8.8.1. Company overview

8.8.2. Company snapshot

8.8.3. Operating business segments

8.8.4. Business performance

8.9. Skye Biologics Inc.

8.9.1. Company overview

8.9.2. Company snapshot

8.9.3. Key strategic moves and developments

8.10. Tissue-Tech Inc. (Amniox Medical Inc.)

8.10.1. Company overview

8.10.2. Company snapshot

8.10.3. Key strategic moves and developments